Menopausia quirúrgica en pacientes con mutación BRCA, el papel de la terapia hormonal / Surgical Menopause in Patients with BRCA Mutation, the Role of Hormone Therapy

Introducción: las mujeres con mutación BRCA1/2 (mBRCA) tienen un riesgo aumentado de desarrollar cáncer de mama (CM) y ovario (CO). La salpingo-oforectomía bilateral (SOB) se asocia con la reducción del riesgo del 80% para CO y un 50% para CM. Se recomienda realizarla entre los 35 y 40 años. Como consecuencia se produce una menopausia prematura, con un impacto negativo sobre la calidad de vida por la presencia de síntomas climatéricos, aumento del riesgo de enfermedad cardiovascular, osteoporosis y riesgo de alteración cognitiva. La terapia hormonal (THM) es el tratamiento más eficaz para la prevención de estos síntomas. Estado del arte: distintos estudios han demostrado un mayor riesgo de CM en mujeres posmenopáusicas que reciben THM en particular con terapia combinada, estrógeno + progesterona (E+P). Según el metanálisis de Marchetti y cols., en las mujeres portadoras de mBRCA que recibieron THM, no hubo diferencias en el riesgo de CM comparando E solo con E+P. En el estudio de Kotsopoulos, incluso se encontró un posible efecto protector en aquellas que usaron E solo. Otro estudio en portadoras sanas demostró que, en las mujeres menores de 45 años al momento de la SOB, la THM no afectó las tasas de CM. Sin embargo, en las mujeres mayores de 45 años, las tasas de CM fueron más altas. Como el esquema de E+P se asocia con un mayor riesgo relativo (RR) de CM, las dosis de progestágenos utilizados se deberían limitar, eligiendo derivados naturales de progesterona, de uso intermitente para disminuir la exposición sistémica. Según diferentes guías internacionales, a las portadoras de mBRCA sanas que se someten a una SOB se les debe ofrecer THM hasta la edad promedio de la menopausia. Conclusión: la menopausia prematura disminuye la expectativa de vida; es por ello que una de las herramientas para mejorar y prevenir el deterioro de la calidad de vida es la THM. El uso de THM a corto plazo parece seguro para las mujeres portadoras de mBRCA que se someten a una SOB antes de los 45 años, al no contrarrestar la reducción del riesgo de CM obtenida gracias a la cirugía. (AU)

Introduction: women with BRCA1/2 (mBRCA) mutation have an increased risk of developing breast (BC) and ovarian (OC) cancer. Bilateral salpingo-oophorectomy (BSO) is associated with an 80% risk reduction for OC and 50% for BC. The recommended age for this procedure is 35 to 40 years. The consequence is premature menopause, which hurts the quality of life due to the presence of climacteric symptoms, increased risk of cardiovascular disease, osteoporosis, and a higher risk of cognitive impairment. Hormone therapy (MHT) is the most effective treatment for preventing these symptoms. State of the art: different studies have shown an increased risk of BC in postmenopausal women receiving MHT, particularly with combined therapy, estrogen + progesterone (E+P). According to the meta-analysis by Marchetti et al., in women carrying mBRCA who received MHT, there was no difference in the risk of BC compared to E alone with E+P. In the Kostopoulos study, there was also a possible protective effect in those who used E alone. Another study in healthy carriers showed that in women younger than 45 years at the time of BSO, MHT did not affect BC rates. However, in women older than 45 years, BC rates were higher. As the E+P scheme is associated with a higher RR of BC, the doses of progestogens should be limited, choosing natural progesterone byproducts of intermittent use to decrease systemic exposure. According to various international guidelines, healthy mBRCA carriers undergoing BSO should be offered MHT until the average age of menopause. Conclusion: premature menopause decreases life expectancy, which is why one of the tools to improve and prevent deterioration of quality of life is MHT. Short-term use of MHT appears safe for women with mBRCA who undergo BSO before age 45 as it does not counteract the reduction in the risk of MC obtained by surgery. (AU)

Efectos de la menopausia temprana en la función pulmonar: revisión integrativa / Effects of early menopause on lung function: an integrative review

La menopausia provoca cambios hormonales y alteraciones sistémicas. La menopausia normal sucede entre los 45-55 años y la menopausia temprana (MT) se desarrolla antes de los 45 años. Revisar la evidencia que señala posibles asociaciones entre la MT y la función pulmonar, analizando específicamente aquellos componentes que se encuentran alterados. Se eligieron estudios transversales y revisiones sistemáticas, en inglés, portugués y español. La búsqueda se realizó de marzo a noviembre de2022, en PubMed y Scopus, aemás de búsquedas manuales. La calidad metodológica fue analizada utilizando la escala Strengthening the Reporting of Observational Studies in Epidemiology para los estudios observacionales, y el Ameasurement Tool to Assess Systematic Review para las revisiones. Se encontraron 698 estudios, 12 seleccionados para calificación metodológica, cinco excluidos. Al final del análisis metodológico, se obtuvieron seis estudios transversales y una revisión sistemática, llevados a cabo en Reino Unido, Europa y Asia. Hay una tendencia para asociación de la MT a un patrón ventilatorio restrictivo. Sin embargo la evidencia sigue siendo escasa y se sugiere la realización de nuevos estudios.

Menopause causes hormonal changes and systemic alterations. Normal menopause is when this event occurs between the ages of 45 and 55, and early menopause (EM) when it develops earlier than 45 years. To review the evidence that indicates possible associations between EM and lung function, specifically analyzing those components that are altered. Cross-sectional and systematic reviews studies, published from 2000-2022, in English, Portuguese and Spanish were selected from March to November 2022, in PubMed and Scopus and through manual searches. Methodological quality was assessed using the Strengthening the Reporting of Observational Studies in Epidemiology scale for observational studies, and the Measurement Tool to Assess Systematic Review for reviews. 698 studies were found, 12 were selected for methodological quality review and 5 were excluded. At the end of methodological analysis, 6 cross-sectional studies and 1 systematic review were obtained, carried out in United Kingdom, Europe and Asia. There is a tendency for EM to be associated with restrictive ventilatory pattern. However, the evidence is scarce and further studies are suggested.

Avaliação da função sexual e da atividade física em mulheres após tratamento do câncer de colo de útero: estudo transversal / Assessment of sexual function and physical activity in women after cervical cancer treatment: a cross-sectional study

Introdução: O tratamento do câncer do colo do útero (CCU) promove menopausa precoce em mulheres diagnosticadas durante o menacme. A consequente interrupção abrupta da produção dos hormônios ovarianos impacta na sexualidade e outras áreas da vida da mulher, inclusive sua atividade física. É possível que a atividade física influencie a atividade sexual nessas mulheres. Objetivo: Avaliar o nível de atividade física e a função sexual nas mulheres após o tratamento oncológico e verificar se a atividade física está associada a melhor função sexual. Método: Este estudo transversal incluiu mulheres tratadas para câncer do colo do útero em um hospital de referência em oncologia no Brasil, com idade entre 18 e 50 anos, submetidas a ooforectomia bilateral e/ou radioterapia pélvica há, no máximo 11 anos. O desfecho primário foi o estado da função sexual e do nível de atividade física e a correlação entre eles e o tratamento oncológico. As mulheres responderam os questionários Female Sexual Function Index (FSFI) e o International Physical Activity Questionnaire (IPAQ) por entrevista remota entre agosto de 2021 a julho de 2022. Resultados: 50 mulheres foram entrevistadas. A média de idade foi 50 anos (DP = ±5). Todas as mulheres que tinham atividade sexual apresentaram algum nível de disfunção sexual. A maior parte das mulheres era fisicamente ativa (60%). Não houve correlação do perfil de atividade física, nem da função sexual com o tratamento oncológico realizado. Não houve associação entre atividade física e maior qualidade na função sexual. Conclusão: Todas as mulheres que relataram relação sexual tinham disfunção sexual e a maioria delas era ativa fisicamente.

Background: Cervical cancer (CC) treatment promotes early menopause in women diagnosed during menacme. The consequent abrupt interruption of the production of ovarian hormones impacts on sexuality and other areas of a woman's life, including her physical activity. It is possible that physical activity influences sexual activity in these women. Aim: To evaluate the level of physical activity and sexual function in women after cancer treatment and to verify whether physical activity is associated with better sexual function. Method: This cross-sectional study included women aged between 18 and 50 years treated for cervical cancer at a reference hospital in oncology in Brazil, who had undergone bilateral oophorectomy and/or pelvic radiotherapy for a maximum of 11 years. The primary outcome was sexual function status and physical activity level and understanding between them and cancer treatment. The women answered the Female Sexual Function Index (FSFI) and the International Physical Activity Questionnaire (IPAQ) by remote interview between August 2021 and July 2022. Results: 50 women were interviewed. The mean age was 50 years (SD = ±5). All women who had sexual activity had some level of sexual dysfunction. Most women were physically active (60%). There was no change in the physical activity profile or sexual function with the oncological treatment performed. There was no association between physical activity and better quality of sexual function. Conclusion: All women who reported sexual intercourse had sexual dysfunction and most of them were physically active.

Performance of the Fracture Risk Assessment Tool Associated with Muscle Mass Measurements and Handgrip to Screen for the Risk of Osteoporosis in Young Postmenopausal Women / Desempenho da ferramenta de avaliação de risco de fraturas associada à medida de massa muscular e à preensão manual no rastreio de risco de osteoporose em mulheres jovens pós-menopáusicas

Abstract Objective To evaluate the improvement in screening accuracy of the Fracture Risk Assessment Tool (FRAX) for the risk of developing osteoporosis among young postmenopausal women by associating with it clinical muscle mass measures. Methods A sample of postmenopausal women was submitted to calcaneal quantitative ultrasound (QUS), application of the FRAX questionnaire, and screening for the risk of developing sarcopenia at a health fair held in the city of São Bernardo do Campo in 2019. The sample also underwent anthropometric measurements, muscle mass, walking speed and handgrip tests. A major osteoporotic fracture (MOF) risk ≥ 8.5% on the FRAX, a classification of medium risk on the clinical guideline of the National Osteoporosis Guideline Group (NOGG), and a QUS T-score ≤ -1.8 sd were considered risks of having low bone mass, and QUS T-score ≤ -2.5sd, risk of having fractures. Results In total, 198 women were evaluated, with a median age of 64±7.7 years, median body mass index (BMI) of 27.3±5.3 kg/m2 and median QUS T-score of -1.3±1.3 sd. The accuracy of the FRAX with a MOF risk ≥ 8.5% to identify women with T-scores ≤ -1.8 sd was poor, with an area under the curve (AUC) of 0.604 (95% confidence interval [95%CI]: 0.509-0.694) for women under 65 years of age, and of 0.642 (95%CI: 0.571-0.709) when age was not considered. Including data on muscle mass in the statistical analysis led to a significant improvement for the group of women under 65 years of age, with an AUC of 0,705 (95%CI: 0.612-0.786). The ability of the high-risk NOGG tool to identify T-scores ≤ -1.8 sd was limited. Conclusion Clinical muscle mass measurements increased the accuracy of the FRAX to screen for osteoporosis in women aged under 65 years.

Resumo Objetivo Avaliar a melhora da precisão da Fracture Risk Assessment Tool (Ferramenta de Avaliação do Risco de Fraturas, FRAX, em inglês) no rastreio do risco de desenvolver osteoporose em mulheres jovens pós-menopáusicas com a associação de medidas clínicas de massa muscular e preensão manual. Métodos Uma amostra de mulheres pós-menopáusicas foi submetida a ultrassom quantitativo (USQ) de calcâneo, à aplicação do questionário FRAX, e rastreadas quanto ao risco de desenvolver sarcopenia em uma feira de saúde realizada em 2019 em São Bernardo do Campo. Alémdisso, a amostra tambémfoi submetida a antropometria, e a testes de massa muscular, velocidade de marcha, e preensão manual. Um risco de grandes fraturas osteoporóticas (GFOs) ≥ 8,5% no FRAX, classificação de médio risco nas diretrizes clínicas do National Osteoporosis Guideline Group (NOGG), e T-score no USQ ≤ -1,8 dp foram considerados riscos de ter baixa massa óssea, e T-score no QUS ≤ -2,5 sd, risco de ter fraturas. Resultados Ao todo, 198 mulheres foram avaliadas, com idade média de 64±7,7 anos, índice de massa corporal (IMC) médio de 27,3±5,3 kg/m2, e T-score médio no USQ de -1,3±1,3 sd. A precisão do FRAX comumrisco de GFO≥ 8,5% para identificar mulheres com T-score ≤ -1,8 dp foi precária, com uma área sob a curva (ASC) de 0,604 (intervalo de confiança de 95% [IC95%]: 0,509-0,694), para mulheres menores de 65 anos de idade, e de 0,642 (IC95%: 0,571-0,709) quando a idade não foi considerada. A inclusão de dados da massa muscular na análise estatística levou a uma melhora significativa no grupo menor de 65 anos de idade, com uma ASC de 0,705 (IC95%: 0,612-0,786). A habilidade da ferramenta NOGG de alto risco para identificar T-scores ≤ -1,8 dp foi limitada. Conclusão As medidas clínicas da massa muscular aumentaram a precisão do FRAX no rastreio de osteoporose em mulheres menores de 65 anos de idade.

A experiência da menopausa precoce em mulheres com câncer de mama com idade inferior a 45 anos / The experience of premature menopause induced by breast cancer treatment in women under 45 years old

O aumento da incidência de câncer de mama em mulheres jovens, com menos de 45 anos, aliado à cronicidade da doença tem despertado a necessidade de melhor compreender as repercussões do tratamento com o intuito de construir um cuidado em saúde que atenda as especificidades das mulheres jovens com câncer de mama. A menopausa precoce está entre os aspectos com importante impacto à vida das mulheres jovens. Desta forma, o presente estudo teve por objetivo compreender o processo de luto decorrente da menopausa precoce induzida pelo tratamento do câncer de mama em mulheres com menos de 45 anos. Para atingir o objetivo proposto realizamos um estudo qualitativo, a partir do método clínico-qualitativo e da análise de conteúdo. Empregamos a entrevista aberta e o Procedimento de Desenhos-Estórias (D-E) como principais instrumentos de coleta de dados, que foram complementados com questionário de dados sociodemográficos e dados clínicos. Os dados foram analisados a partir da compreensão do luto como uma Transição Psicossocial e de teorias psicodinâmicas que permitiram aprofundar a compreensão dos aspectos subjetivos do processo de luto decorrente da menopausa precoce induzida pelo tratamento. A análise dos dados permitiu identificar cinco categorias: Corpo devastado e o ataque ao suporte identitário: "Eu mesma não me reconheço"; Necessidade de se familiarizar com o novo corpo: "É normal sentir isso?"; De corpo inteiro: "Meu corpo inteiro, eu notei que ele mudou"; O sofrimento associado à possibilidade da infertilidade: "É o meu Tendão de Aquiles"; e "Como fogo e gelo": Vicissitudes do desejo sexual criando desencontros na relação com o parceiro íntimo. Foi possível identificar diversas perdas simbólicas decorrentes da experiência da menopausa precoce que foram significativas para as mulheres jovens em tratamento. O conjunto de mudanças corporais fragiliza a base identitária do ser mulher jovem e antecipa algumas vivências ligadas ao envelhecimento. Observou-se que alguns lutos puderam ser ressignificados, enquanto outros apresentaram características de luto complicado, por não terem sido integrados a uma nova identidade. Os aspectos psicodinâmicos identificados no contexto do tratamento do câncer de mama e da consequente menopausa precoce, evidenciaram uma regressão das necessidades básicas, como necessidade de proteção e cuidado, bem como, sentimentos de culpa, ambivalência, medo da perda, medo da morte e desproteção. Tendências construtivas como a busca pela autonomia, pelo desenvolvimento pessoal e o desejo de recuperar a saúde também foram observados. Esperamos que o conhecimento produzido contribua para a melhor compreensão dos lutos simbólicos decorrentes da experiência da menopausa precoce induzida pelo tratamento do câncer de mama, para que o cuidado integral à mulher jovem com câncer de mama considere as repercussões da menopausa à saúde e vida dessas mulheres auxiliando na elaboração de tais lutos

The increased incidence of breast cancer in young women under 45 years of age and the chronicity of the disease has aroused the need to better understand the repercussions of treatment in order to offer a health care that meets the specificities of young women with breast cancer. Premature menopause is among the aspects with an important impact on young women's lives. Thus, the presente study aimed to understand the process of mourning resulting from premature menopause induced by breast cancer treatment in women under 45 years old. To achieve the proposed objective, a qualitative study was carried out through a clinial-qualitative approach and content analysis. We used the open interview and the Story-Drawing procedure as the mais tools for data collection, complemented with a questionnaire of sociodemographic data and clinical data. The data were analyzed considering the framework of grief as a Psychossocial Process and psychodinamic theories allowed a more profound understanding on subjective aspects of grief process resulting from the premature menopause induced by breast cancer treatment. The data analysis allowed the identification of five categories: Devastated body and the attack on identity support: "I don't recognize myself"; Need to familiarize yourself with the new body: "Is it normal to feel this?", All of me: "My whole body has changed", Suffering associeted with infertility: "Its my Achilles tendon", "Like fire and ice": vicissitudes of sexual desire creating mismatches in the relationship with the intimate partner. It was possible to identify many symbolic losses resulting from the experience of premature menopause that were relevant to young women in treatment. The set of body changes weakens the identity base of being a young woman and anticipates some experiences related to aging. Some losses could be elaborated, while others presented complicated grief characteristics because they were not integrated into a new identity. The psychodynamic aspects identified in the context of breast cancer treatment and consequent early menopause, showed a regression of basic needs, such as need for protection and care, as well as feelings of guilt, ambivalence, fear of loss, fear of death and unprotection. Constuctive trends such as the search for autonomy, personal development and the desire to recover health were also observed. It is expected that the knowledge produced will contribute to a better understanding of symbolic grief resulted from the experience of premature menopause induced by breast cancer treatment, so that comprehensive health care for young women with breast cancer considers the repercussions of menopause on the health and life of these women assisting in the elaboration of such mourning

Insuficiencia ovárica primaria en adolescentes: revisión de la literatura a propósito de un caso clínico / Primary ovarian insufficiency in adolescents: review of the literature regarding a clinical case

El objetivo de este manuscrito es realizar una revisión y actualización de la literatura de la insuficiencia ovárica primaria (IOP) en población adolescente, a partir del diagnóstico, manejo y seguimiento de un caso clínico. La insuficiencia ovárica primaria se define como la menopausia en una mujer antes de los 40 años, acompañada de amenorrea, hipogonadismo hipergonadotrópico e infertilidad. Su prevalencia varía entre 1 a 2%, y en mujeres menores de 20 años su prevalencia es un caso de cada 10,000. Aunque se sabe que muchas afecciones pueden llevar a una IOP, la más común es la causa idiopática. La presentación clínica es diversa, y varios trastornos diferentes pueden también, llevar a esta condición. CASO CLÍNICO: Se presenta el caso de una adolescente de 17 años, previamente sana, con historia de amenorrea secundaria, no embarazada, con examen físico general y ginecológico normal. Se solicita estudio analítico complementario resultando con niveles de hormona folículo estimulante (FHS), estradiol (E2) y hormona antimülleriana (AMH) compatibles con una insuficiencia ovárica como la observada en la posmenopausia. Se inicia terapia hormonal (TH) clásica con estradiol y progesterona, siendo posteriormente reemplazada por anticoncepción hormonal combinada (AHC) oral, coincidente con el inicio de vida sexual, con respuesta favorable y sangrados regulares. La IOP tiene graves consecuencias para la salud incluyendo trastornos psicológicos como angustia, síntomas depresivos o depresión, infertilidad, osteoporosis, trastornos autoinmunes, cardiopatía isquémica, y un mayor riesgo de mortalidad. La enfermedad de Hashimoto es el trastorno autoinmune más frecuente asociado a la IOP. Su tratamiento y diagnóstico deben establecerse de forma precoz para evitar consecuencias a largo plazo. La terapia con estrógenos es la base del tratamiento para eliminar los síntomas de la deficiencia de estrógenos, además de evitar las consecuencias futuras del hipogonadismo no tratado. También el manejo debe incluir los siguientes dominios: fertilidad y anticoncepción, salud ósea, problemas cardiovasculares, función psicosexual, psicológica y neurológica, informando a los familiares y a la paciente sobre la dimensión real de la IOP y la necesidad de tratamiento multidisciplinario en muchos casos. CONCLUSIÓN: El caso presentado, pese a ser infrecuente, permite abordar de manera sistematizada el diagnostico de IOP y evaluar alternativas de manejo plausibles para evitar graves consecuencias en la salud, así como conocer respuesta clínica y de satisfacción de la adolescente.

The objective of this manuscript is to review and update the literature on primary ovarian insufficiency (POI) in an adolescent population, based on the diagnosis, management and follow-up of a clinical case. Primary ovarian insufficiency is defined as menopause in a woman before the age of 40, accompanied by amenorrhea, hypergonadotropic hypogonadism, and infertility. Its prevalence varies between 1 to 2%, and in women under 20 years of age its prevalence is one case in every 10,000. Although it is known that many conditions can lead to POI, the most common is the idiopathic cause. The clinical presentation is diverse, and several different disorders can also lead to this condition. CLINICAL CASE: The case of a 17-year-old adolescent, previously healthy, with a history of secondary amenorrhea, not pregnant, with a normal general physical and gynecological examination is presented. A complementary analytical study is requested, resulting in levels of follicle stimulating hormone (FHS), estradiol (E2) and anti-müllerian hormone (AMH) compatible with ovarian insufficiency such as that observed in postmenopause. Classic hormonal therapy (HT) with estradiol and progesterone was started, later being replaced by combined hormonal contraception (CHC), coinciding with the beginning of sexual life, with a favorable response and regular bleeding. POI has serious health consequences including psychological disorders such as distress, depressive symptoms or depression, infertility, osteoporosis, autoimmune disorders, ischemic heart disease, and an increased risk of mortality. Hashimoto's disease is the most common autoimmune disorder associated with POI. Its treatment and diagnosis must be established early to avoid long-term consequences. Estrogen therapy is the mainstay of treatment to eliminate the symptoms of estrogen deficiency, in addition to avoiding the future consequences of untreated hypogonadism. Management should also include the following domains: fertility and contraception, bone health, cardiovascular problems, psychosexual, psychological and neurological function, informing family members and the patient about the real dimension of POI and the need for multidisciplinary treatment in many cases. CONCLUSION: The case, although infrequent, allows a systematic approach to the diagnosis of POI and evaluate plausible management alternatives to avoid serious health consequences, as well as to know the clinical response and satisfaction of the adolescent.

Avaliação dos fatores de risco para osteoporose e aplicação da ferramenta FRAX clínico em idoso / Evaluation of risk factors for osteoporosis and application of the clinical FRAX tool in the elderly

RESUMO: A osteoporose é caracterizada pela fragilidade óssea e mudanças em sua microarquitetura. O seu principal desfecho clínico é a fratura por baixo impacto. Uma das principais ferramentas de avaliação clínica do risco de fratura osteoporótica é o FRAX. Este trabalho objetiva avaliar os fatores de risco para osteoporose e a indicação de tratamento em idosos. Foi realizado um estudo transversal, descritivo, com abordagem quantitativa e qualitativa, por meio de um questionário, com 145 pacientes que foram atendidos no setor ambulatorial do DeCos Day Hospital, no período de novembro de 2017 a abril de 2018. Observou-se que a osteoporose prevaleceu no sexo feminino, sedentários e com idade média de 71 anos. A presença de fratura predominou na faixa etária de 70 a 79 anos e nenhum participante fazia tratamento específico para a osteoporose. Conclui-se que orientações dietéticas saudáveis são importantes como medida preventiva e a ferramenta FRAX poderia ser utilizada para estimar a probabilidade de fratura, visto que a densitometria não é a acessível a toda a população

ABSTRACT: Osteoporosis is characterized by bone fragility and changes in its microarchitecture. Its main clinical outcome is a low impact fracture. One of the main tools for clinical assessment of the risk of osteoporotic fracture is FRAX. This work aims to evaluate the risk factors for osteoporosis and the indication for treatment in the elderly. A cross-sec-tional, descriptive study with a quantitative and qualitative approach was carried out, using a questionnaire, with 145 patients who were assisted in the outpatient sector of the Hospital de Dia DeCos, from November 2017 to April 2018. Osteoporosis prevailed in women, sedentary, and with an average age of 71 years old. The presence of fractures predominated in the age group from 70 to 79 years old, and no participant used specific treatment for osteoporosis. It is concluded that dietary guidelines are important as a preventive measure, and a FRAX tool can be used to estimate the probability of fracture since densitometry is not accessible to the entire population.

Gynecological cancer and metabolic screening of 1001 elderly Brazilian women

SUMMARY OBJECTIVE The aim of this study was to evaluate gynecological cancer and metabolic screening of Brazilian women aged 65 years or older. METHODS This retrospective descriptive study was conducted by including 1,001 Brazilian patients of the gynecological geriatric outpatient office of our institution to evaluate the influence of age on gynecological cancer and metabolic screening parameters at the first clinical visit. All patients were divided into three groups: a) 65 to 69 years; b) 70 to 74 years; c) ≥ 75 years. We considered clinical, laboratorial, and image data as variables of this study. The Chi-square test was used to assess the proportion of differences among the age groups, and Kruskal-Wallis was used for quantitative variables. RESULTS The values of BMI and height in the group over 75 years was lower than that of the 65 to 69 years (p = 0.001). Regardless of the age group, high arterial blood pressure levels were found in 85.45% of participants. Also, many patients had glucose intolerance in the blood. The pelvic ultrasonography showed abnormal endometrial echo thickness (> 5 mm) in 6.14% of patients, but with no significant statistical difference between the age groups. A total of 4.04% of patients had ovaries with high volume values ( > 6.1 mL). Abnormal mammography (BI-RADS 3 or 4) was observed in 12.21%. CONCLUSIONS our data suggest that a great reduction in BMI and stature is more frequent in the group over 75 years. Also, systemic arterial hypertension and carbohydrate disturbance are frequent morbidities in women over 65 years.

RESUMO OBJETIVO O objetivo deste trabalho foi estudar retrospectivamente alguns dados clínicos, laboratoriais e imagens de um grupo de idosas brasileiras. MÉTODOS Estudo observacional retrospectivo realizado com inclusão de 1.001 mulheres brasileiras atendidas no ambulatório de geriatria ginecológica de nossa instituição. Foram analisados: a idade dos pacientes na primeira consulta clínica e a idade na menopausa natural; alguns achados clínicos durante um exame ginecológico; resultados de análises laboratoriais. Considerou-se a relação dessas variáveis com o grupo da idade das mulheres. O teste do qui-quadrado foi utilizado para avaliar os dados e para algumas variáveis, Kruskal-Wallis ou Anova. RESULTADOS A avaliação do IMC e da estatura nas diferentes faixas etárias das mulheres mostrou que, com o aumento da idade, há diminuição do IMC e da estatura (p=0,001). Nível anormal de pressão arterial estava presente em 85,45%. De acordo com o grupo de idade, as medidas laboratoriais foram avaliadas pelo método estatístico Kruskal-Wallis, e a Anova mostrou diferença estatisticamente significante apenas no valor da creatinina, com pequeno aumento com a idade. A ultrassonografia pélvica foi alterada com espessura endometrial normal (>5 mm) em 29 (6,14%), mas sem diferença estatística significativa com os grupos de idade, e os ovários mostraram sete (4,04%) com volume anormal (>6,1). Mamografia anormal (BI-Rads 3 ou 4) foi observada em 104 pacientes (12,21%). CONCLUSÕES O estudo conclui que, com o aumento da idade, há redução do IMC e da estatura. A hipertensão é morbidade frequente. Os dados laboratoriais e a avaliação de imagens deste estudo são importantes para aumentar o conjunto de informações sobre mulheres idosas e talvez para melhorar a assistência à saúde.

Association between Age at Natural Menopause with Diabetes and Prediabetes

BACKGROUND: Previous studies have reported that fasting insulin and blood glucose levels are higher in postmenopausal than in premenopausal women and that insulin resistance was more serious in postmenopausal women. The effects of menopause on glucose metabolism have been well studied, but it is unclear whether age at menopause onset is associated with fasting blood sugar and HbA1c levels. The purpose of this study is to determine the effect of menopause age on diabetes and prediabetes.METHODS: We retrospectively analyzed data from the Sixth Korea National Health and Nutrition Examination Survey (2013–2015). The participants were 2,156 naturally menopausal women, except diabetes, stroke, coronary artery disease and cancer patients. The study population was divided into four groups according to the age of natural menopause onset ( < 40, 40–44, 45–55, and ≥56 years). Diagnosis of diabetes and prediabetes was based on the American Diabetes Association guideline. The association between menopause age and diabetes or prediabetes was analyzed by multiple logistic regression.RESULTS: Women reaching menopause at 40–44 years were 4.901 times more likely to have diabetes (odds ratio [OR], 4.901; 95% confidence interval [95% CI], 1.353–17.756, P=0.016) than those who reached menopause at an age of ≥56 years. Women with menopause at age < 40 years were 2.839 times more likely to have diabetes or prediabetes (OR, 2.839; 95% CI, 1.012–7.968, P=0.047).CONCLUSION: Women with premature menopause (< 40 years) have high risk of developing diabetes or prediabetes, and women with a menopause age of 40–44 years have high risk of developing diabetes.

Distrofia ósea esclerosante mixta / Mixed-sclerosing-bone-dystrophy

El término "distrofia ósea esclerosante mixta" describe la combinación de las características radiológicas correspondientes a melorreostosis, osteopoiquilosis y osteopatía estriada, como entidades individuales, que ocurren en un mismo paciente. El objetivo de esta comunicación es presentar el caso clínico de una paciente con diagnóstico de distrofia ósea esclerosante mixta y, a partir de este caso, realizar una revisión sobre el tema. (AU)

The term "mixed-sclerosing-bone-dystrophy" describes the combination of the radiological characteristics corresponding to melorheostosis, osteopoikilosis and osteopathia striata, as individual conditions, ocurring in the same patient. The aim of this communication is to present the clinical case of a patient diagnosed with mixed-sclerosing-bone-dystrophy and, based on this case, to undertake a review of this condition. (AU)

Idade da menopausa em mulheres idosas do município de São Paulo: fatores associados e análise de sobrevida / Age at menopause among elderly women in the São Paulo municipality associated factors and survival analysis

Introdução: O crescimento do número de idosos no Brasil tem aumentado o interesse em identificar os determinantes da sua sobrevida e da incidência de doenças crônicas. A menopausa é definida como a cessação permanente da menstruação e está associada à diminuição da secreção de estrógenos por perda da função folicular, marcando o fim da fase reprodutiva na vida feminina. A idade da menopausa tem sido associada em alguns estudos internacionais com a mortalidade e algumas causas de morbidade, mas faltam estudos sobre o tema no Brasil. Esta tese será apresentada por meio de 3 artigos. O primeiro analisou os fatores associados à idade da menopausa natural em mulheres do estudo SABE (Saúde, Bem-estar e Envelhecimento). O tabagismo e a escolaridade estiveram estatisticamente associados com uma menopausa mais cedo nas três coortes analisadas: 2000, 2006 e 2010. Mulheres fumantes atuais tiveram 35% maior risco de ter menopausa precoce (HR=1.35, 95% CI: 1.12, 1.62) e as ex-fumantes 27% maior risco (HR=1.27, 95% CI: 1.09, 1.50), em comparação com as mulheres que nunca fumaram. Em relação à escolaridade, as mulheres com 8 anos ou mais de estudos tiveram 33% menor risco de menopausa precoce (HR=0.67, 95% CI: 0.50, 0.89) comparadas às mulheres sem escolaridade. Estado civil e número de filhos estiveram associados a uma menopausa mais tardia na coorte 2006. No segundo artigo, foi realizada uma análise de sobrevida segundo a idade da menopausa natural das mulheres pertencentes à coorte 2000. Foram identificados 444 óbitos de mulheres até 2016. Mulheres com menopausa precoce tiveram 48% de maior risco de mortalidade geral (HR=1.48, 95% IC: 1.03, 2.14) comparadas às mulheres com idade de menopausa entre os 50 e 54 anos (referência). Em relação à mortalidade específica, mulheres entre 41 e 49 anos apresentaram o dobro de risco de mortalidade por neoplasias em comparação com o grupo de referência. No terceiro artigo, foi realizada uma revisão sistemática e meta-análise dos fatores reprodutivos associados à menopausa natural. Os três fatores estudados apresentaram uma associação com a menopausa tardia. As mulheres com uso de anticoncepcionais orais em relação àquelas que não relataram uso de anticoncepcionais orais (HR=0.86, CI=0.79, 0.92), as com idade da menarca >=13 anos comparadas àquelas com idade da menarca

Introduction: The increase of the elderly population in Brazil has raised concerns about their care and the determinants of survival and incidence of chronic diseases. Menopause is defined as the permanent end of a woman's menstruation and is associated with the decline of the release of estrogens due to loss of follicular function, indicating the end of the reproductive phase of a woman's life. Age at menopause has been linked with mortality and morbidity in international studies. The first article of this thesis analyzed the factors associated with age at natural menopause among women of the SABE study cohort (Health, Well-Being, Aging). Smoking and education were associated with earlier menopause for the three waves analyzed: 2000, 2006 and 2010. Current smokers had 35% higher risk of earlier natural menopause (HR=1.35, 95% CI: 1.12, 1.62) and former smokers had 27% higher risk of earlier natural menopause (HR=1.27, 95% CI: 1.09, 1.50), in comparison with never smokers. Regarding education, women with 8 years or more of formal education had 33% lower risk of earlier natural menopause (HR=0.67, 95% CI: 0.50, 0.89) than women with no education. Marital status and parity were associated with later age at natural menopause only in 2006. In the second article, a survival analysis was performed according to age at natural menopause in women from SABE 2000. We found a total of 444 deaths from 2000 to 2016. Women with earlier menopause had 48% increased risk of all-cause mortality (HR=1.48, 95% IC: 1.03, 2.14) compared to women with age at menopause between 50 and 54 years (reference group). Regarding cause-specific mortality, women with ages at natural menopause between 41 and 49 had twice the risk of cancer mortality compared to the reference group. In the third article, we performed a systematic review and meta-analysis of the reproductive factors associated with natural menopause. The three factors analyzed were statistically associated with later menopause: women with use of oral contraceptives before menopause compared to women with no use of oral contraceptive (HR=0.86, CI=0.79, 0.92), women with age at menarche >=13 compared to women with age at menarche

Insuficiencia ovárica prematura / Premature ovarian failure

Introducción La menopausia es el paso final en el proceso denominado envejecimiento ovárico. La disminución relacionada con la edad en el número de folículos dicta el inicio de la irregularidad del ciclo y el cese final de la menstruación. En paralelo, la descomposición en la calidad de los ovocitos contribuye a la disminución gradual de la fertilidad y la aparición final de esterilidad.

Introduction Menopause is the final step in the process called ovarian aging. The decrease related to age in the number of follicles dictates the beginning of the irregularity of the cycle and the final cessation of menstruation. In parallel, the decomposition in the quality of the oocytes contributes to the gradual decrease of fertility and the final appearance of sterility.

The Relationship between Hormone Replacement Therapy and Periodontal Disease in Postmenopausal Women / 치위생과학회지

The purpose of this study was to investigate the relationship between hormone replacement therapy (HRT) and periodontal disease in postmenopausal women using data from the 4th and 5th Korea National Health and Nutrition Examination Survey. A total of 5,482 postmenopausal women aged 45~75 years were included as study subjects in the final analysis. The HRT group comprised 1,035 postmenopausal women who had received HRT for at least one month, and the non-HRT group comprised 4,447 postmenopausal women who did not receive HRT. The chi-square test was used to confirm the bivariate relationship between the variables. Multinomial logistic regression analysis was used to adjust for covariance (age, education, family income, body mass index, age of menopause, alcohol, smoking, dental visit < 1 per year, use of oral care products, and frequency of tooth brushing per day). After adjusting for all covariates, HRT was found to be associated with periodontal disease. In particular, the relationship between HRT and periodontal disease was more evident in older women and women younger than 45 years of menopausal age. The relationship between HRT and periodontal disease was stronger in women who brushed their teeth less than 3 times per day, women without regular oral examination, and women who did not use oral hygiene products. The results of this study confirmed the importance of actively considering hormone therapy when determining policy recommendations for postmenopausal women. Especially, health programs such as HRT, regular dental examination, and oral care are needed for older women who have undergone premature menopause.

Relationship between Early Menopause and Periodontal Disease in Korean Postmenopausal Women / 치위생과학회지

The purpose of this study was to evaluate the relationship between early menopause and periodontal disease in postmenopausal women using data from the 6th Korean National Health and Nutrition Examination Survey (2013~2015). A study was conducted with 2,048 postmenopausal women aged 45 to 74 years. Participants were divided into the early menopause group (menopause occurring at age 45 years or before) and normal menopause group (menopause occurring after age 45 years). A community periodontal index greater than or equal to code 3 was used to define periodontal treatment needs. A chi-square test was used to confirm the bivariate relationship between the variables. Multinomial logistic regression analysis was used to adjust for covariates (age, education, family income, body mass index, alcohol drinking, smoking, visiting dentist in the last year, use of oral care products, frequency of tooth brushing per day). The risk of periodontal disease was higher in the early menopause group after adjusting for potential confounders (odds ratio, 1.59). In particular, the relationship between early menopause and periodontal disease was more evident in women with low education and those who did not use oral care products. The findings of this study suggest that early menopause is a significant factor of periodontal disease in Korean women.

A general description for Chinese medicine in treating premature ovarian failure / 中国结合医学杂志

Premature ovarian failure (POF) is a kind of gynecological disease that causes amenorrhea, infertility, menopause and urogenital symptoms. Currently hormone replacement therapy (HRT) is the most popular choice for women with POF to get rid of menopausal syndrome. However, as the popularization of Chinese herbs made Chinese medicine (CM) shine new lights, physicians are able to treat POF with both meno-herbs and integrated therapy. HRT has its own indications and contraindications. For example, unexplained vaginal bleeding, acute liver damage, liver dysfunction, vascular embolization, and breast cancer are all contraindications of HRT, and CM is taken by more physicians as an adjuvant therapy. This review, including a range of common Chinese herbs and formulations according to the existing literature, provides a general description of CM treating POF from the aspects of mechanisms and clinical application. It also highlights acupuncture as a unique physiotherapy for POF. Although the validity of CM has been supported by the evidence of many preclinical trials, clinical trials and meta-analysis, the adverse events with CM therapy still exist and no guarantee has been made for its safety. This review concludes the updated information for CM treating POF contributing to further studies.

Análise histomorfométrica dos cardiomiócitos e deposição de colágeno no músculo cardíaco de ratas ooforectomizadas / Histomorphometric analysis of cardiomyocytes and collagen deposition in the heart muscle of ovariectomized rats

Esse estudo objetivou avaliar o efeito da ooforectomia sob os parâmetros histomorfométricos dos cardiomiócitos e quantificação de colágeno em ratas Wistar. Vinte ratas foram utilizadas e separadas em dois grupos: GI - ooforectomizada e GII - sham-ooforectomizada. Após a recuperação anestésica os animais foram acomodados em gaiolas e separados nas condições de ciclo claro/escuro 12/12h por um período de 6 meses. Passado o período experimental, os animais foram anestesiados, o coração retirado e mergulhado em formaldeído a 10%. Os fragmentos dos ventrículos foram submetidos ao processamento histológico e corados com hematoxilina e eosina. As análises histomorfométricas (área celular e área e volume nuclear) foram realizadas pelo microscópio de luz e software ImageJ versão 1.44. Os dados foram submetidos à análise ANOVA e quando significantes, complementados pelo teste t de student (p<0,001). Observou-se uma diminuição significativa das áreas celular e nuclear dos cardiomiócitos do grupo GI quando comparado ao grupo GII, bem como a área ocupada, pelo colágeno, no músculo cardíaco foi maior em GI, quando comparado a GII. Diante disso, conclui-se que as alterações observadas nos cardiomiócitos do grupo GI, sugerem uma maior atividade apoptótica nesse grupo, devido à diminuição dos níveis séricos do estrógeno provocado pela ooforectomia e o aumento da área ocupada pelo colágeno, no grupo ooforectomizado, está associada ao efeito cardioprotetor do estrógeno.

This study aimed to evaluate the effect of oophorectomy on the morphometric variables of cardiomyocytes and quantification collagen in Wistar rats. Twenty rats were used and divided into two groups: GI - ovariectomized and GII - sham-ovariectomized. After recovery from anesthesia the animals were housed in separate cages and under the conditions of light / dark cycle 12/12h for a period of six months. After the experimental period, the animals were anesthetized, the heart removed and immersed in 10% formaldehyde. The fragments of the ventricles were subjected to histological analysis and stained with hematoxylin and eosin. Histomorphometric analysis (cell area and nuclear area and volume) were performed by light microscopy and ImageJ software version 1.44. The data were submitted to ANOVA and when significant, complemented by Student's t test (p<0.001). There was a significant decrease in cellular and nuclear areas of the GI cardiomyocytes compared to GII and the area occupied by collagen was greater in cardiac muscle GI, when compared to GII. Therefore, it is concluded that the changes observed in the GI group cardiomyocytes, suggest a higher apoptotic activity in this group, due to decreased serum estrogen levels caused by ovariectomy and increased area occupied by collagen in oophorectomized group is associated the cardioprotective effect of estrogen.

Study of Estradiol, Testosterone and DHEA-S Status in Women After Surgical Menopause.

Aims and Objectives : The study was done to assess the hormones namely Estradiol, Testosterone, and Dehydroepiandrosterone-sulphate (DHEAs) one day before operation and on ninth post-operative day following surgical menopause. Materials and Methods : This is a cross sectional observational study. The study was done amongst the thirty four women aged between 40-48 years with functioning uterus and at least one ovary, not using any exogenous hormone preparations affecting ovarian function for last three months and having at least one menstrual period in three previous months were included in this study. They had under gone hysterectomy with bilateral salpingooophorectomy due to non-ovarian pathology. Fasting venous blood samples were taken one day before operation and on ninth post-operative day of surgical menopause Serum concentration of estradiol, testosterone, and DHEAS were determined. Results : The circulating estradiol level decreased significantly (p = 0.043) from 161 pg/ml preoperatively to 108 pg/ml. on ninth post-operative day after surgical menopause. In spite of reduction in mean testosterone level from 0.11 ng/ml. to 0.09 ng/ml. following surgical menopause, which is statistically insignificant (p = 0.247).There was no significant difference between the serum DHEA-S level before and after surgical menopause. A significant positive correlation was observed between pre-operative circulatory levels of DHEA-S with that of estradiol while there was absence of any significant co-relations corelations between any of the other pairs of values. Conclusion : The circulating estradiol level decreased significantly on ninth day after surgical menopause and significant positive correlation between pre-operative circulatory levels of DHEA-S with that of estradiol, but there was no significant co-relation between post-operative circulating estradiol with that of DHEA-S. Testosterone did not show any significant relation with estradiol neither in pre-operative period nor in post-operative condition.

Autosomal Translocation Patient Who Experienced Premature Menopause: A Case Report

Premature ovarian failure (POF) is a condition in which the ovarian functions of hormone production and oocyte development become impaired before the typical age for menopause. POF and early menopause are present in a broad spectrum of gonad dysgenesis, from a complete cessation of ovarian function to an intermittent follicle maturation failure. Actually POF has been identified as a genetic entity (especially chromosome X), but data on genetic factors of premature menopause are limited. Until now, several cases revealed that inactivation of X chromosomes has an effect on ages of premature menopause and females with balanced or unbalanced X-autosome translocations can have several reproductive problems. On the other hand, there have been a few data that was caused by autosome-autosome translocation can lead. Therefore we report a relevant case of POF with translocation between chromosomes 1 and 4. She had her first menstrual period at the age of 12, and after 7 years she stopped menstruation. Chromosomal analysis showed 46, XX, t (1;4) (p22.3;q31.3). While evaluating this rare case, we could review various causes (especially genetic factors) of POF. To remind clinicians about this disease, we report a case of POF caused by autosome-autosome translocation with a literature review.

Repercussões do tratamento quimioterápico sobre a função ovariana / Repercussions of chemotherapy on ovarian function

Os tratamentos quimioterápicos atuais têm aumentado bastante a sobrevida de pacientes acometidas por diversos tipos de câncer; porém, podem causar falência ovariana e infertilidade. É importante o médico estar atento aos riscos de ocorrência dessas sequelas para tentar preservar a qualidade de vida das pacientes. Este artigo apresenta uma revisão acerca de recursos propedêuticos que podem ser utilizados na avaliação da função ovariana e de dados sobre a possível disfunção ovariana pós-quimioterapia. Normalmente essa disfunção não ocorre imediatamente após o tratamento, manifestando-se mais tarde como menopausa precoce. Procedimentos podem ser realizados com o intuito de se preservar a fertilidade e/ou a função ovariana.

New chemotherapic treatment have been raising the lifetime of the patients with cancer. However, important sequelas of these treatments, as ovary failure and infertility, may occur. It is important to the doctor to be aware of the risks of these side effects occurrence in order to maintain the quality of life for those patients. This article presents a review about the propedeutic resources that can be used to analyze the ovarian function and important data about the possible ovary dysfunction after chemotherapy. In most patients the ovary dysfunction will not occur immediately after the treatment expressing later as an early menopause scene. Some procedures can be performed in order to try to preserve the fertility and the ovary function.

Endometrial tuberculosis causing amenorrhea and abnormal uterine bleeding in a lupus patient treated with cyclophosphamide

BACKGROUND: Amenorrhea may occur in patients with lupus treated with cyclophosphamide. This is commonly attributed to primary ovarian failure leading to infertility -- a possible complication of cyclophosphamide. Urogenital tuberculosis (TB) can be a rare cause of amenorrhea and infertility in lupus patients.OBJECTIVE: To present a case of endometrial TB causing amenorrhea and abnormal uterine bleeding in a patient with lupus nephritis treated with cyclophosphamide.CASE: A 32-year-old Filipino female, who was diagnosed with lupus nephritis, was managed with high dose steroid and intravenous (IV) cyclophosphamide. Lupus nephritis improved with treatment, but she subsequently developed amenorrhea and vaginal spotting for two months. Symptoms were initially attributed to premature ovarian failure due to cyclophosphamide.Gynecologic examination showed thickened endometrium with normal ovaries and uterus on ultrasound. Dilatation and curettage was performed. Histopathology of endometrial curetting revealed chronic granulomatous endometritis with Langhans giant cells. Endometrial TB was diagnosed, and anti-Koch's therapy was started. The patient showed a favourable response, with resumption of normal menstruation after only the first month of treatment.CONCLUSION: This paper emphasizes the importance of considering a wide range of differential diagnosis for gynecologic symptoms in patients with lupus. Tuberculosis should be considered in areas of high endemicity